Search
Patexia Research
Case number 2019-2156

Genentech, Inc. v. Amgen Inc. > Documents

Date Field Doc. No.Description (Pages)
Apr 23, 2021 0 GENENTECH, INC. v. AMGEN INC. [RULE 36 JUDGMENT] [nonprecedential] (0)
Apr 13, 2020 86 Mandate issued to the United States District Court for the District of Delaware. Service as of this date by the Clerk of Court. [686414] [JAB] [Entered: 04/13/2020 02:21 PM] (1)
Mar 6, 2020 85 JUDGMENT. AFFIRMED. Issued pursuant to Federal Circuit Rule 36. Terminated on the merits after oral argument. COSTS: Costs taxed against Appellant(s). Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [676803] [JAB] [Entered: 03/06/2020 09:16 AM] (2)
Mar 3, 2020 84 Submitted after ORAL ARGUMENT by Robert J. Gunther, Jr. for Genentech, Inc. and Mr. Jeffrey A. Lamken for Amgen Inc. Panel: Judge: Prost , Judge: Bryson , Judge: Wallach. [675766] [JCP] [Entered: 03/03/2020 10:22 AM] (0)
Feb 6, 2020 83 Response to notice of oral argument from the Appellant Genentech, Inc.. [668830] [19-2156] [Robert Gunther] [Entered: 02/06/2020 09:19 AM] (3)
Feb 6, 2020 82 **TEXT ONLY** ORDER granting motion to withdraw attorney Nancy J. Gettel [81] filed by Appellee Amgen Inc. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [668811] [JAB] [Entered: 02/06/2020 08:00 AM] (0)
Feb 5, 2020 81 MOTION of Appellee Amgen Inc. to withdraw counsel Nancy J. Gettel [Consent: unopposed]. Service: 02/05/2020 by email. [668792] [19-2156] [Jeffrey Lamken] [Entered: 02/05/2020 06:20 PM] (6)
Feb 4, 2020 80 Response to notice of oral argument from the Appellee Amgen Inc.. [668433] [19-2156] [Jeffrey Lamken] [Entered: 02/04/2020 05:56 PM] (3)
Jan 23, 2020 79 NOTICE OF ORAL ARGUMENT. Panel: 2003D. Case scheduled March 3, 2020 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, NW Washington, DC 20439), Courtroom 201. Response to Notice of Oral Argument due: 02/14/2020. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. [665620] [JAB] [Entered: 01/23/2020 04:06 PM] (2)
Dec 23, 2019 78 Notice from Appellee Amgen Inc. regarding conflicts with oral argument. None. Service: 12/23/2019 by email. [658481] [19-2156] [Jeffrey Lamken] [Entered: 12/23/2019 01:43 PM] (0)
Dec 19, 2019 77 Notice from Appellant Genentech, Inc. regarding conflicts with oral argument. None. Service: 12/19/2019 by email. [657772] [19-2156] [Robert Gunther] [Entered: 12/19/2019 11:32 AM] (0)
Dec 19, 2019 76 Citation of Supplemental Authority pursuant to Fed. R. App. P. 28(j) for Appellant Genentech, Inc.. Service: 12/19/2019 by email. [657770] [19-2156] [Robert Gunther] [Entered: 12/19/2019 11:31 AM] (5)
Dec 18, 2019 75 6 paper copies of the Corrected Confidential Joint Appendix (Vol. I - II) [67] received from Appellant Genentech, Inc.. [657702] [CJF] [Entered: 12/19/2019 08:08 AM] (0)
Dec 18, 2019 74 6 paper copies of the Confidential Reply Brief [51] received from Appellant Genentech, Inc.. [657701] [CJF] [Entered: 12/19/2019 08:05 AM] (0)
Dec 18, 2019 73 6 paper copies of the Corrected Confidential Opening Brief [48] received from Appellant Genentech, Inc.. [657700] [CJF] [Entered: 12/19/2019 08:04 AM] (0)
Dec 17, 2019 72 6 paper copies of the Corrected Confidential Opening Response Brief [65] received from Appellee Amgen Inc.. [657232] [CJF] [Entered: 12/17/2019 04:13 PM] (0)
Dec 16, 2019 71 Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [656682] [JAL] [Entered: 12/16/2019 10:24 AM] (1)
Dec 16, 2019 70 Outstanding paper copies of all briefs and appendices must be submitted within five business days from the date of issuance of this notice. See Fed. Cir. R. 25(c)(1). [656680] [JAL] [Entered: 12/16/2019 10:22 AM] (0)
Dec 16, 2019 69 REMINDER: All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.4(a) and Fed. Cir. R. 47.3 to promptly submit an amended Certificate of Interest (COI) and/or Entry of Appearance (EOA) as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [656668] [JAL] [Entered: 12/16/2019 09:37 AM] (0)
Nov 12, 2019 68 MODIFIED ENTRY: CORRECTED JOINT APPENDIX FILED for Appellant Genentech, Inc. Number of Pages: 1171. Service: 11/12/2019 by email. [648469] --[Edited 12/16/2019 by JAL - Compliance review complete] [William Lee] [Entered: 11/12/2019 09:11 AM] (1171)
Nov 12, 2019 67 MODIFIED ENTRY: CORRECTED CONFIDENTIAL JOINT APPENDIX FILED for Appellant Genentech, Inc. Number of Pages: 1165. Service: 11/12/2019 by email. [648464]--[Edited 12/16/2019 by JAL - Compliance review complete] [William Lee] [Entered: 11/12/2019 09:08 AM] (0)
Nov 11, 2019 66 MODIFIED ENTRY: CORRECTED RESPONSE BRIEF FILED for Appellee Amgen Inc. Number of Pages: 63. Service: 11/11/2019 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of the original version of this brief [45]. See Fed. Cir. R. 31. [648429] --[Edited 12/16/2019 by JAL - Compliance review complete] [Jeffrey Lamken] [Entered: 11/11/2019 04:54 PM] (79)
Nov 11, 2019 65 MODIFIED ENTRY: CORRECTED CONFIDENTIAL RESPONSE BRIEF FILED for Appellee Amgen Inc. Number of Pages: 63. Service: 11/11/2019 by email. [648428]--[Edited 12/16/2019 by JAL - Compliance review complete] [Jeffrey Lamken] [Entered: 11/11/2019 04:50 PM] (0)
Nov 6, 2019 64 NOTICE OF NON-COMPLIANCE: The submissions of Appellant Genentech, Inc., Confidential and Non-Confidential Joint Appendix [53], [54], are not in compliance with the rules of this court (see attached). Compliant documents due on 11/14/2019. Service as of this date by the Clerk of Court. [647368] [TAM] [Entered: 11/06/2019 01:41 PM] (2)
Nov 6, 2019 63 NOTICE OF NON-COMPLIANCE: The submissions of Appellee Amgen Inc., Corrected Confidential and Non-Confidential Response Briefs [61], [62], are not in compliance with the rules of this court (see attached). Compliant documents due on 11/14/2019. Service as of this date by the Clerk of Court. [647307] [TAM] [Entered: 11/06/2019 12:41 PM] (1)
Oct 28, 2019 62 FILED from Appellee Amgen Inc.. Title: CORRECTED CONFIDENTIAL RESPONSE BRIEF. Service: 10/28/2019 by email, US mail. [645285] [19-2156] This document is non-compliant. See Doc No.[63] [Jeffrey Lamken] [Entered: 10/28/2019 05:19 PM] (0)
Oct 28, 2019 61 FILED from Appellee Amgen Inc.. Title: CORRECTED RESPONSE BRIEF. Service: 10/28/2019 by email. [645284] [19-2156] This document is non-compliant. See Doc No.[63] [Jeffrey Lamken] [Entered: 10/28/2019 05:17 PM] (78)
Oct 24, 2019 60 Amended Entry of appearance for Daniel J. Knauss as of counsel for Appellee Amgen Inc.. Service: 10/24/2019 by email. [644605] [19-2156] [Daniel Knauss] [Entered: 10/24/2019 07:32 PM] (2)
Oct 23, 2019 59 NOTICE OF NON-COMPLIANCE: The submissions of Appellee Amgen Inc., Confidential and Non-Confidential Response Briefs [45], [46], are not in compliance with the rules of this court (see attached). Compliant documents due on 10/30/2019. Service as of this date by the Clerk of Court. [644252] [TAM] [Entered: 10/23/2019 03:58 PM] (2)
Oct 17, 2019 58 ORDER filed granting motion to waive confidentiality requirements [50] filed by Appellant Genentech, Inc. The confidential and non-confidential versions of Genentech's reply brief are accepted for filing. Service as of this date by the Clerk of Court. [642869] [LMS] [Entered: 10/17/2019 12:27 PM] (2)
Oct 1, 2019 57 ORDER denying [42] motion to extend time to file brief filed by Amgen Inc. Service as of this date by the Clerk of Court. [639385] [LMS] [Entered: 10/01/2019 01:28 PM] (2)
Sep 27, 2019 56 Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellant Genentech, Inc.. Service: 09/27/2019 by email. [638804] [19-2156] [William Lee] [Entered: 09/27/2019 02:10 PM] (5)
Sep 27, 2019 55 Joint Statement of Compliance with Fed. Cir. R. 33 for Appellant Genentech, Inc. and Appellee Amgen Inc.. Service: 09/27/2019 by email. [638803] [19-2156] [William Lee] [Entered: 09/27/2019 02:09 PM] (4)
Sep 27, 2019 54 FILED from Appellant Genentech, Inc.. Title: APPENDIX. Service: 09/27/2019 by email. [638798] [19-2156] This document is non-compliant. See Doc No.[64] [William Lee] [Entered: 09/27/2019 02:04 PM] (1171)
Sep 27, 2019 53 FILED from Appellant Genentech, Inc.. Title: CONFIDENTIAL APPENDIX. Service: 09/27/2019 by email. [638796] [19-2156] This document is non-compliant. See Doc No.[64] [William Lee] [Entered: 09/27/2019 02:03 PM] (0)
Sep 20, 2019 52 MODIFIED ENTRY: REPLY BRIEF FILED for Appellant Genentech, Inc.. Number of Pages: 30. Service: 09/20/2019 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [637237] --[Edited 10/23/2019 by TAM - compliance review complete] [William Lee] [Entered: 09/20/2019 07:10 PM] (40)
Sep 20, 2019 51 MODIFIED ENTRY: CONFIDENTIAL REPLY BRIEF FILED for Appellant Genentech, Inc.. Number of Pages: 30. Service: 09/20/2019 by email. [637236]--[Edited 10/23/2019 by TAM - compliance review complete] [William Lee] [Entered: 09/20/2019 07:09 PM] (0)
Sep 20, 2019 50 MOTION of Appellant Genentech, Inc. to waive confidentiality requirements [Consent: unopposed]. Service: 09/20/2019 by email. [637234] [19-2156] [William Lee] [Entered: 09/20/2019 07:08 PM] (10)
Sep 12, 2019 49 MODIFIED ENTRY: CORRECTED OPENING BRIEF FILED for Appellant Genentech, Inc.. Number of Pages: 58. Service: 09/12/2019 by email. [635001]--[Edited 10/23/2019 by TAM - compliance review complete] [William Lee] [Entered: 09/12/2019 11:13 AM] (212)
Sep 12, 2019 48 MODIFIED ENTRY: CORRECTED CONFIDENTIAL BRIEF FILED for Appellant Genentech, Inc.. Number of Pages: 58. Service: 09/12/2019 by email. [634999]--[Edited 10/23/2019 by TAM - compliance review complete] [William Lee] [Entered: 09/12/2019 11:12 AM] (0)
Sep 11, 2019 47 ORDER granting motion to waive confidentiality requirements [18] to the extent that Genentech may file a brief marking as confidential the material identified in ECF No. [41]. Service as of this date by the Clerk of Court. [634612] [NL] [Entered: 09/11/2019 11:43 AM] (2)
Sep 4, 2019 46 FILED from Appellee Amgen Inc.. Title: RESPONSE BRIEF. Service: 09/04/2019 by email. [633201] [19-2156] This document is non-compliant. See Doc No.[59] [Jeffrey Lamken] [Entered: 09/04/2019 11:54 PM] (78)
Sep 4, 2019 45 FILED from Appellee Amgen Inc.. Title: CONFIDENTIAL RESPONSE BRIEF. Service: 09/04/2019 by email, US mail. [633200] [19-2156] This document is non-compliant. See Doc No.[59] [Jeffrey Lamken] [Entered: 09/04/2019 11:44 PM] (0)
Aug 29, 2019 44 REPLY of Appellee Amgen Inc. to response [43]. Service: 08/29/2019 by email. [631969] [19-2156] [Jeffrey Lamken] [Entered: 08/29/2019 01:58 PM] (8)
Aug 28, 2019 43 RESPONSE of Appellant Genentech, Inc. to the motion to extend time to file brief [42] filed by Appellee Amgen Inc.. Service: 08/28/2019 by email. [631792] [19-2156] [William Lee] [Entered: 08/28/2019 10:19 PM] (12)
Aug 28, 2019 42 MOTION of Appellee Amgen Inc. to extend the time to 09/11/2019 to file the Appellee's Initial Brief. [Consent: opposed]. Service: 08/28/2019 by email. [631777] [19-2156] [Jeffrey Lamken] [Entered: 08/28/2019 05:49 PM] (7)
Aug 16, 2019 41 Confidential Brief for Plaintiff-Appellant Genentech, Inc. filed by Appellee Amgen Inc. corresponding to Doc. No. [40]. Service: 08/16/2019 by email. [629109] [19-2156] [Michelle Rhyu] [Entered: 08/16/2019 07:43 PM] (0)
Aug 16, 2019 40 RESPONSE of Appellee Amgen Inc. to the clerk order to show cause [39] , clerk order [39]. Service: 08/16/2019 by email. [629107] [19-2156] [Michelle Rhyu] [Entered: 08/16/2019 07:39 PM] (7)
Aug 9, 2019 39 ORDER to show cause. Within seven days from the date of filing of this order, Amgen Inc. is directed to show cause for the material it designates as confidential within Genentech’s brief that redaction is “appropriate and necessary pursuant to a statute, administrative regulation, or court rule.” Fed. Cir. R. 28(d)(1)(A). Service as of this date by the Clerk of Court. [627282] [NL] [Entered: 08/09/2019 01:03 PM] (2)
Aug 7, 2019 38 ORDER filed denying [8] motion filed by Genentech, Inc. (Per Curiam). Service as of this date by the Clerk of Court. [626605] [LMS] [Entered: 08/07/2019 10:23 AM] (2)
Aug 2, 2019 37 Docketing Statement for the Appellee Amgen Inc.. Service: 08/02/2019 by email. [625827] [19-2156] [Michelle Rhyu] [Entered: 08/02/2019 06:50 PM] (4)
Aug 1, 2019 36 Docketing Statement for the Appellant Genentech, Inc.. Service: 08/01/2019 by email. [625463] [19-2156] [William Lee] [Entered: 08/01/2019 05:14 PM] (4)
Aug 1, 2019 35 Sealed or confidential document received [Confidential Reply of Plaintiff-Appellant Genentech, Inc. in Support of Its Emergency Motion for an Injunction Pending Resolution of Appeal and Motion to Expedite Briefing on Appeal] (corresponding to Doc No. [34]) for Appellant Genentech, Inc.. Service: 08/01/2019 by email. [625307] [19-2156] [William Lee] [Entered: 08/01/2019 02:05 PM] (0)
Aug 1, 2019 34 REPLY of Appellant Genentech, Inc. to response [27]. Service: 08/01/2019 by email. [625304] [19-2156] [William Lee] [Entered: 08/01/2019 02:02 PM] (60)
Jul 30, 2019 33 Corrected Entry of appearance for Alissa Wood as of counsel for Appellee Amgen Inc.. Service: 07/30/2019 by email. [624605] [19-2156] [Alissa Wood] [Entered: 07/30/2019 03:04 PM] (2)
Jul 30, 2019 32 Entry of appearance for Brian Kao as of counsel for Appellee Amgen Inc.. Service: 07/30/2019 by email. [624591] [19-2156] [Brian Kao] [Entered: 07/30/2019 02:36 PM] (2)
Jul 30, 2019 31 Entry of appearance for Lois Kwasigroch as of counsel for Appellee Amgen Inc.. Service: 07/30/2019 by email. [624582] [19-2156] [Lois Kwasigroch] [Entered: 07/30/2019 02:24 PM] (2)
Jul 30, 2019 30 NOTICE OF NON-COMPLIANCE: The submission of Appellee Amgen Inc., Entry of Appearance [26], is not in compliance with the rules of this court (see attached). Compliant document due on 08/06/2019. Service as of this date by the Clerk of Court. [624382] [TAM] [Entered: 07/30/2019 09:06 AM] (1)
Jul 29, 2019 29 Certificate of Interest for Appellee Amgen Inc.. Service: 07/29/2019 by email. [624345] [19-2156] [Michelle Rhyu] [Entered: 07/29/2019 11:43 PM] (2)
Jul 29, 2019 28 Sealed or confidential document received [Confidential Response of Appellee Amgen Inc. to the motion to stay pending appeal under Rule 8] (corresponding to Doc No. [27]) for Appellee Amgen Inc.. Service: 07/29/2019 by email. [624344] [19-2156] [Michelle Rhyu] [Entered: 07/29/2019 11:40 PM] (0)
Jul 29, 2019 27 RESPONSE of Appellee Amgen Inc. to the motion for stay pending appeal under Rule 8/18 [8] filed by Appellant Genentech, Inc.. Service: 07/29/2019 by email. [624343] [19-2156] [Michelle Rhyu] [Entered: 07/29/2019 11:35 PM] (137)
Jul 29, 2019 26 Notice of Correction to the correction notice Doc No. [17] for Appellee Amgen Inc.from Alissa Wood. Service: 07/29/2019 by email. [624245] [19-2156] This document is non-compliant. See Doc No.[30] [Michelle Rhyu] [Entered: 07/29/2019 03:49 PM] (2)
Jul 29, 2019 25 Entry of appearance for Wendy A. Whiteford as of counsel for Appellee Amgen Inc.. Service: 07/29/2019 by email. [624242] [19-2156] [Wendy Whiteford] [Entered: 07/29/2019 03:45 PM] (2)
Jul 29, 2019 24 Entry of appearance for Nancy J. Gettel as of counsel for Appellee Amgen Inc.. Service: 07/29/2019 by email. [624185] [19-2156] [Nancy Gettel] [Entered: 07/29/2019 02:44 PM] (2)
Jul 29, 2019 23 Entry of appearance for Lucas M. Walker as of counsel for Appellee Amgen Inc.. Service: 07/29/2019 by email. [623926] [19-2156] [Lucas Walker] [Entered: 07/29/2019 08:41 AM] (2)
Jul 29, 2019 22 Entry of appearance for Jeffrey A. Lamken as of counsel for Appellee Amgen Inc.. Service: 07/29/2019 by email. [623921] [19-2156] [Jeffrey Lamken] [Entered: 07/29/2019 08:36 AM] (2)
Jul 29, 2019 21 Entry of appearance for Michael G. Pattillo as of counsel for Appellee Amgen Inc.. Service: 07/29/2019 by email. [623918] [19-2156] [Michael Pattillo] [Entered: 07/29/2019 08:32 AM] (2)
Jul 26, 2019 20 FILED from Appellant Genentech, Inc.. Title: CONFIDENTIAL OPENING BRIEF. Service: 07/26/2019 by email. [623879] [19-2156] This brief has been corrected. See Doc No[48] [William Lee] [Entered: 07/26/2019 11:50 PM] (0)
Jul 26, 2019 19 FILED from Appellant Genentech, Inc.. Title: OPENING BRIEF. Service: 07/26/2019 by email. [623878] [19-2156] This brief has been corrected. See Doc No.[49] [William Lee] [Entered: 07/26/2019 11:44 PM] (212)
Jul 26, 2019 18 MOTION of Appellant Genentech, Inc. to waive confidentiality requirements [Consent: opposed]. Service: 07/26/2019 by email. [623877] [19-2156] [William Lee] [Entered: 07/26/2019 11:41 PM] (9)
Jul 26, 2019 17 Notice of Correction to the attorney entry of appearance Doc No. [15] for Appellee Amgen Inc.. Service: 07/26/2019 by email. [623754] [19-2156] [Alissa Wood] [Entered: 07/26/2019 11:54 AM] (2)
Jul 26, 2019 16 NOTICE OF NON-COMPLIANCE: The submission of Appellee Amgen Inc., Entry of Appearance for Alissa Wood [15], is not in compliance with the rules of this court (see attached). Compliant document due on 08/02/2019. Service as of this date by the Clerk of Court. [623676] [TAM] [Entered: 07/26/2019 08:54 AM] (2)
Jul 25, 2019 15 Entry of appearance for Alissa Wood as of counsel for Appellee Amgen Inc.. Service: 07/25/2019 by email. [623569] [19-2156] This document is non-compliant. See Doc No.[16] [Alissa Wood] [Entered: 07/25/2019 03:46 PM] (2)
Jul 24, 2019 14 Entry of appearance for Benjamin S. Lin as of counsel for Appellee Amgen Inc.. Service: 07/24/2019 by email. [623324] [19-2156] [Benjamin Lin] [Entered: 07/24/2019 05:53 PM] (2)
Jul 24, 2019 13 Entry of appearance for Daniel J. Knauss as of counsel for Appellee Amgen Inc.. Service: 07/24/2019 by email. [623214] [19-2156] [Daniel Knauss] [Entered: 07/24/2019 03:06 PM] (2)
Jul 22, 2019 12 Entry of appearance for Michelle S. Rhyu as principal counsel for Appellee Amgen Inc.. Service: 07/22/2019 by email. [622697] [19-2156] [Michelle Rhyu] [Entered: 07/22/2019 07:28 PM] (2)
Jul 22, 2019 11 Entry of appearance for Orion Armon as of counsel for Appellee Amgen Inc.. Service: 07/22/2019 by email. [622691] [19-2156] [Orion Armon] [Entered: 07/22/2019 07:18 PM] (2)
Jul 22, 2019 10 ORDER filed. ECF No. 7 [7] is granted. The motion is accepted for filing. Any response to ECF No. 8 [8] is due no later than seven days from the date of this order. Any reply is due no later than three days from the filing of the response. (Per Curiam). Service: 07/22/2019 by clerk. [622505] [LMS] [Entered: 07/22/2019 12:40 PM] (2)
Jul 19, 2019 9 Sealed or confidential document received [Confidential Motion of Appellant Genentech, Inc. for an emergency stay pending appeal under Rule 8/18] (corresponding to Doc No. [8]) for Appellant Genentech, Inc.. Service: 07/19/2019 by email. [622346] [19-2156] [William Lee] [Entered: 07/19/2019 06:43 PM] (0)
Jul 19, 2019 8 MOTION of Appellant Genentech, Inc. for an emergency stay pending appeal under Rule 8/18 [Consent: opposed]. Service: 07/19/2019 by email. [622345] [19-2156] [William Lee] [Entered: 07/19/2019 06:38 PM] (197)
Jul 19, 2019 7 MOTION of Appellant Genentech, Inc. to waive confidentiality requirements [Consent: unopposed]. Service: 07/19/2019 by email. [622343] [19-2156] [William Lee] [Entered: 07/19/2019 06:36 PM] (9)
Jul 19, 2019 6 Certificate of Interest for Appellant Genentech, Inc.. Service: 07/19/2019 by email. [622254] [19-2156] [William Lee] [Entered: 07/19/2019 02:12 PM] (3)
Jul 19, 2019 5 Entry of appearance for Daralyn J. Durie as of counsel for Appellant Genentech, Inc.. Service: 07/19/2019 by email. [622253] [19-2156] [Daralyn Durie] [Entered: 07/19/2019 02:10 PM] (2)
Jul 19, 2019 4 Entry of appearance for Andrew J. Danford as of counsel for Appellant Genentech, Inc.. Service: 07/19/2019 by email. [622252] [19-2156] [Andrew Danford] [Entered: 07/19/2019 02:08 PM] (2)
Jul 19, 2019 3 Entry of appearance for Robert J. Gunther, Jr. as of counsel for Appellant Genentech, Inc.. Service: 07/19/2019 by email. [622249] [19-2156] [Robert Gunther] [Entered: 07/19/2019 02:06 PM] (2)
Jul 19, 2019 2 Entry of appearance for William F. Lee as principal counsel for Appellant Genentech, Inc.. Service: 07/19/2019 by email. [622245] [19-2156] [William Lee] [Entered: 07/19/2019 02:03 PM] (2)
Jul 19, 2019 1 Appeal docketed. Received: 07/19/2019. [622241]Entry of Appearance due 08/02/2019. Certificate of Interest is due on 08/02/2019. Docketing Statement due 08/02/2019. Appellant's brief is due 09/17/2019. [TAM] [Entered: 07/19/2019 01:55 PM] (33)
Menu